Type III secretion (TTS) is an essential virulence factor for Shigella flexneri, the causative agent of shigellosis. The Shigella TTS apparatus (TTSA) is an elegant nano‐machine that is composed of a basal body, an external needle to deliver effectors into human cells, and a needle tip complex that controls secretion activation. IpaD is at the tip of the nascent TTSA needle where it controls the first step of TTS activation. The bile salt deoxycholate (DOC) binds to IpaD to induce recruitment of the translocator protein IpaB into the maturing tip complex. We recently used spectroscopic analyses to show that IpaD undergoes a structural rearrangement that accompanies binding to DOC. Here, we report a crystal structure of IpaD with DOC bound a...
Shigella are bacteria that are responsible for millions of infections and hundreds of thousands of d...
Type III secretion (T3S) systems are used by numerous Gram-negative pathogenic bacteria to inject vi...
This is the peer reviewed version of the following article: ChemMedChem. 2017 Sep 21; 12(18): 1534–1...
Shigella flexneri uses its type III secretion apparatus (TTSA) to inject host-altering proteins into...
Type three secretion systems (T3SS) are specialized nanomachines that support infection by injecting...
Shigellosis (bacillary dysentery) results from infection by Shigella spp and represents one of the l...
Type III secretion (TTS) is an essential virulence function for Shigella flexneri that delivers effe...
Type three secretion systems (T3SS) are specialized nanomachines that support infection by injecting...
Shigella flexneri is a Gram-negative enteric pathogen that is the predominant cause of bacillary dys...
Summary: Type III secretion apparatus (T3SA) are complex nanomachines that insert a translocation po...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
This is the publisher's version, also available electronically from http://iai.asm.org/content/74/8/...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Shigella flexneri uses its type III secretion apparatus (TTSA) to deliver invasins into human cells....
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Shigella are bacteria that are responsible for millions of infections and hundreds of thousands of d...
Type III secretion (T3S) systems are used by numerous Gram-negative pathogenic bacteria to inject vi...
This is the peer reviewed version of the following article: ChemMedChem. 2017 Sep 21; 12(18): 1534–1...
Shigella flexneri uses its type III secretion apparatus (TTSA) to inject host-altering proteins into...
Type three secretion systems (T3SS) are specialized nanomachines that support infection by injecting...
Shigellosis (bacillary dysentery) results from infection by Shigella spp and represents one of the l...
Type III secretion (TTS) is an essential virulence function for Shigella flexneri that delivers effe...
Type three secretion systems (T3SS) are specialized nanomachines that support infection by injecting...
Shigella flexneri is a Gram-negative enteric pathogen that is the predominant cause of bacillary dys...
Summary: Type III secretion apparatus (T3SA) are complex nanomachines that insert a translocation po...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
This is the publisher's version, also available electronically from http://iai.asm.org/content/74/8/...
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Shigella flexneri uses its type III secretion apparatus (TTSA) to deliver invasins into human cells....
The type III secretion system (T3SS) is an essential virulence factor for Shigella flexneri, providi...
Shigella are bacteria that are responsible for millions of infections and hundreds of thousands of d...
Type III secretion (T3S) systems are used by numerous Gram-negative pathogenic bacteria to inject vi...
This is the peer reviewed version of the following article: ChemMedChem. 2017 Sep 21; 12(18): 1534–1...